These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative vaccine-specific and other injectable-specific risks of injection-site sarcomas in cats. Srivastav A, Kass PH, McGill LD, Farver TB, Kent MS. J Am Vet Med Assoc; 2012 Sep 01; 241(5):595-602. PubMed ID: 22916856 [Abstract] [Full Text] [Related]
4. The current understanding and management of vaccine-associated sarcomas in cats. Vaccine-Associated Feline Sarcoma Task Force. J Am Vet Med Assoc; 2005 Jun 01; 226(11):1821-42. PubMed ID: 15934252 [No Abstract] [Full Text] [Related]
8. Comparison of the histology and immunohistochemistry of vaccination-site and non-vaccination-site sarcomas from cats in New Zealand. Aberdein D, Munday JS, Dyer CB, Knight CG, French AF, Gibson IR. N Z Vet J; 2007 Oct 01; 55(5):203-7. PubMed ID: 17928895 [Abstract] [Full Text] [Related]
10. The potential role of inflammation in the development of postvaccinal sarcomas in cats. Macy DW, Hendrick MJ. Vet Clin North Am Small Anim Pract; 1996 Jan 01; 26(1):103-9. PubMed ID: 8825569 [Abstract] [Full Text] [Related]
12. Feline vaccine-associated sarcomas: current studies on pathogenesis. Hendrick MJ. J Am Vet Med Assoc; 1998 Nov 15; 213(10):1425-6. PubMed ID: 9828935 [No Abstract] [Full Text] [Related]
19. Do postvaccinal sarcomas occur in Australian cats? Burton G, Mason KV. Aust Vet J; 1997 Feb 15; 75(2):102-6. PubMed ID: 9066965 [Abstract] [Full Text] [Related]